Tags
- 1D00C3
- 23andMe
- 3-V Biosciences
- 3SBio
- 454 Life Sciences
- 5AM Solutions
- 6R-BH4
- A.P. Pharma
- A0001
- AAB-001
- AAIPharma
- Aastrom Biosciences
- AB Science
- Abbott Labs
- AbCheck
- AbCRO
- Abgenix
- Abingdon Life Sciences
- Abiomed
- abiraterone
- Ablynx
- Abraxane
- Abraxis BioScience
- Abraxis Health
- Abraxis Pharmaceutical
- ABSORB
- ABT-894
- ABthrax
- AC Immune
- Acadia Pharmaceuticals
- ACAM2000
- Acambis
- Acanya
- ACC-001
- Accelerator Corporation
- Acceleron
- Accentia Pharmaceuticals
- Accera
- Access Pharmaceuticals
- Accupril
- ACE-031
- Acell
- AcelleRX Therapeutics
- Acetavance
- Acetylon Pharmaceuticals
- ACH-1625
- Achaogen
- Achillion Pharmaceuticals
- Aclasta
- aclidinium bromide
- acomplia
- Acorda Therapeutics
- ACP-104
- ACP-106
- Acrux
- actavis
- Actavis Totowa
- Actelion
- Actemra
- Actient Pharmaceuticals
- Actimis
- Activaero
- Active Biotech
- ActoGenix
- Actos
- ACU-4492
- Acucela
- Acura Pharmaceuticals
- Acurian
- Acurox
- Acusphere
- Acuvax
- ACX10061
- ACZ885
- AD 337
- Adamas Pharmaceuticals
- Adams Respiratory
- AdcockIngram
- Adderall
- Addex Pharmaceuticals
- Addrenex Pharmaceuticals
- Adenosine Therapeutics
- Adeona Pharmaceuticals
- Aderis Pharmaceuticals
- ADH-1
- ADHD
- ADHD patch
- Adherex
- Adimab
- adjuvant
- Adlea
- Adnexus Therapeutics
- Adolor
- Adrian Adams
- Advagraf
- Advair
- Advanced Cell Technology
- Advanced Life Sciences
- Advanced Viral Research
- Advancis Pharmaceutical
- AdvanDx
- Advaxis
- advent
- ADVENTRX Pharmaceuticals
- adverse events
- Advexin
- Advinus
- ADX10059
- Aegerion Pharmaceuticals
- AEGR-733
- Aeolus Pharmaceuticals
- AeroLEF
- Aerovance
- Aerovant
- AesRx
- AEterna Zentaris
- AEZS-108
- Affimed Therapeutics
- Affitech Therapeutics
- Affomix
- Affymax
- affymetrix
- Afinitor
- Aflibercept
- afluria
- AFM 13
- Afresa
- Afrezza
- Africa
- Aganocide
- age related macular degeneration
- Agendia
- Agennix
- Agensys
- Aggrastat
- AGI Therapeutics
- AGI-1067
- Agile Therapeutics
- Agilent Technologies
- Aging
- Agios Pharmaceuticals
- Agros Therapeutics
- Aidan King
- AIDSVAS
- Aileron Therapeutics
- AkaRx
- Akebia
- Akela Pharma
- Akesis Pharmaceuticals
- Akikin Pharmaceuticals
- Akorn
- AKR-501
- Akrimax Pharmaceuticals
- Akten
- Akzo Nobel
- Alan Frazier
- Alan Levin
- Alan Trounson
- Alba Bioscience
- Alba Therapeutics
- Albany Molecular Research
- Albuferon
- Alcon
- ALD518
- Aldagen
- Alder Biopharmaceuticals
- Alemtuzumab
- Alessandro Banchi
- Alex Gorsky
- Alexander Fleming
- Alexandria Real Estate
- Alexion Pharmaceuticals
- Alexis Borisy
- Alexza Pharmaceuticals
- Alfa wasserman
- Alfacell
- Algeta
- Alimera Sciences
- Alimta
- Alios BioPharma
- Alizyme
- Alkermes
- ALKS 6931
- Allergan
- Allergy Therapeutics
- alli
- Allos
- Allostera Pharma
- allosteric modulators
- Allyson Schwartz
- Almac Group
- Almirall
- almorexant
- Alnara Pharmaceuticals
- Alnylam Pharmaceuticals
- alogliptin
- Alopexx
- Alpha Innotech
- AlphaGenix
- Alpharadin
- Alpharma
- AlphaVax
- ALS Therapy Development
- ALS-357
- Alseres Pharmaceuticals
- Alta Partners
- Altabax
- altana
- Altea Therapeutics
- Altor BioScience
- Altus Pharmaceuticals
- ALVAC
- alvimopan
- Alvine Pharmaceuticals
- Alzheimer's
- Alzhemed
- AM240 MCR
- AMAG Pharmaceuticals
- Amalyte Pharmaceuticals
- Amarin
- Amaya
- AmbioPharm
- Ambit Biosciences
- Ambrilia Biopharma
- Ambrx
- American Cancer Society
- American Medical Association
- AmerisourceBergen
- Amgen
- Amicus Therapeutics
- Amir Nashat
- Amoxicillin
- Ampligen
- Amplimed
- Ampyra
- AMR Technology
- Amsterdam Molecular Therapeutics
- Amulet Pharmaceuticals
- Amylin pharmaceuticals
- amyloid beta
- amyotrophic lateral sclerosis
- Amyris Biotechnologies
- AN2690
- ANA598
- ANA773
- ANA975
- anacetrapib
- Anacor Pharmaceuticals
- Anadys Pharmaceuticals
- analysts
- AnaMar Medical
- Anaphore
- Anaptys Biosciences
- Anascorp
- Anders Ekblom
- Andreas Struengmann
- Andrew von Eschenbach
- Andrew Witty
- Andrin Oswald
- AndroScience
- Androxal
- Andrx
- Anemia drugs
- Anergis
- Anesiva
- Aneustat
- Angiocept
- Angiomax
- Angion Biomedica
- Angiotech Pharmaceuticals
- Angiotensin
- anidulafungin
- Anika Therapeutics
- Animal health
- Animal Liberation Front
- animal rights activists
- Ann Arbor
- Anne Wojcicki
- Anormed
- Antares Pharma
- Anthera
- anthrax
- anthrax vaccine
- anti-counterfeiting
- Anti-TNF
- antibiotic
- antibodies
- Antibody 806
- antidepressant
- antigen
- Antigen Discovery
- Antigenics
- antisense
- Antisense Pharma
- Antisoma
- antithrombotic theory
- antiviral drug
- ANX-514
- ANX-530
- AP23573
- apaziquone
- APD125
- Apeiron Biologics
- Apex Bioventures
- APF530
- Apitope Technology
- apixaban
- Aplenzin
- ApoA-I Milano
- Apogenix
- Apoptone
- Apotex
- Applied Biosystems
- Applied Genetic Technologies Corporation
- AppTec
- Apridra
- APT Pharmaceuticals
- Aptuit
- Aradigm
- Arana Therapeutics
- Aranesp
- ARC16
- ARCA
- Arcalyst
- ARCH Venture Partners
- Archemix
- Archer Pharmaceuticals
- Archimedes
- Arcion Therapeutics
- Arcutis
- Arcxis Biotechnologies
- Ardana
- Ardea BioSciences
- Arena Pharmaceuticals
- Arete Therapeutics
- arGEN-X
- arGentis
- Arginetix
- Argolyn Bioscience
- Argos Therapeutics
- ARIAD Gene Therapeutics
- Ariad Pharmaceuticals
- Ariana Pharma
- Aridol
- Arigene
- Arius
- Arizona
- Ark Therapeutics
- Arlene Chiu
- Arno Therapeutics
- Arnold Schwarzenegger
- Arpida
- ARQ 197
- ArQule
- Array BioPharma
- Arriva
- Arrow Group
- Arrow International Limited
- Arrowhead Research
- ARRY-403
- ART104
- ART621
- arthritis
- Arthur Higgins
- Arthur Levinson
- ARX424
- Aryx Therapeutics
- Arzerra
- arzoxifene
- AS1402
- AS1404
- ASA404
- Ascendis Pharma
- Ascent Therapeutics
- Ascenta Therapeutics
- ASCO
- ASCO 2009
- Asenapine
- Asentar
- Asia
- Aspen Pharmacare
- Aspen Technology
- Asphelia Pharmaceuticals
- Aspreva Pharmaceuticals
- asset sale
- assets
- Astelin
- Astellas Pharma
- Astepro
- Asterand
- Astex Therapeutics
- asthma
- AstraZeneca
- Asuragen
- atacicept
- ataluren
- Athenagen
- Athera Biotechnologies
- Atherogenics
- Atherosclerosis
- Athersys
- Atlantos
- Atlas Venture
- Aton Pharma
- Atria
- atrial fibrillation
- Atrium Innovations
- ATryn
- Atu027
- AtuRNAi
- aTyr Pharma
- Auriga Laboratories
- Aurigene
- Auspex Pharmaceuticals
- Australia
- AutekBio
- autism
- AutoImmune
- autoimmune disease
- Auxilium Pharmaceuticals
- Avalon Pharmaceuticals
- Avandia
- Avanir Pharmaceuticals
- Avant Immunotherapeutics
- Avantome
- Avastin
- AVE5530
- Avecia Biologics
- Aveed
- Avelox
- AVEO Pharmaceuticals
- Averion
- Avexa
- AVI Biopharma
- Avian Flu
- Avian flu vaccine
- Avid Biosciences
- Avid Radiopharmaceuticals
- Avigen
- Avila Therapeutics
- AVN316
- AVN994
- Avonex
- Axcan Pharma
- Axentis Pharma
- Axial Biotech
- Axikin Pharmaceuticals
- Axiron
- axitinib
- AxoGen
- Axona
- AZ-002
- AZ-004
- AZD1446
- AZD3480
- AZD6244
- Azilect
- Azur Pharma
- BA058
- balaglitazone
- baldness therapies
- Balsalazide
- Baltimore
- Baminercept
- bankruptcy
- bapineuzumab
- Barack Obama
- Baraclude
- Barr Pharmaceuticals
- Barrier Therapeutics
- Bart Chernow
- Basilea Pharmaceutica
- Bausch & Lomb
- Bavarian Nordic
- Bavituximab
- Baxter International
- Bayer Healthcare
- Bayer Schering
- Bayhill Therapeutics
- Bazedoxifene
- BCI-540
- BDSI
- Beckman Coulter
- Beike Biotech
- Belatacept
- Belgium
- belinostat
- Bellco Health
- Bellus Health
- benign prostatic hyperplasia
- Benlysta
- Benson Tsang
- Bentley Pharmaceuticals
- Bepreve
- Berkely HeartLab
- Berna Biotech
- Bernard Poussot
- Betagenon
- Betaseron
- betrixaban
- bevirimat
- Bextra
- BG Medicine
- BG-12
- BGC 945
- Bial
- bicifadine
- Bidil
- Bifeprunox
- Big Biotech
- Big Pharma
- Bilcare
- Bill and Melinda Gates Foundation
- Bill Weldon
- Bill Wells
- Billionaire
- BIND Biosciences
- Binocrit
- BIO
- BIO 2008
- BIO 2009
- Bioalliance Pharma
- BioAssets
- BioComp Pharma
- Biocompatibles International
- Biocon
- Biocryst
- BioCurex
- biodefense
- Biodel
- BioDelivery Sciences
- BioDuro
- Bioenvision
- BioFocus DPI
- Biogen Idec
- Biogenerics
- Bioheart
- BioInvent
- Biolex Therapeutics
- BiolineRx
- Biologics
- BioMarck Pharmaceuticals
- BioMarin Pharmaceutical
- biomarkers
- BioMedomics
- BioMerieux
- BioMimetic Therapeutics
- Biomira
- BioMS Medical
- BioNanomatrix
- BioNexus
- Bioniche Life Sciences
- Bionomics
- BioNovo
- biopharmaceutical company
- BioProcessors
- biopure
- BioSante Pharmaceuticals
- biosimilar
- BioSpecifics Technologies
- BioSynthema
- Biota
- BIOTECanada
- biotech
- Biotech CEO
- Biotech CEO pay
- biotech company closing
- Biotech company news
- Biotech deals
- biotech drugs
- Biotech graveyard
- biotech growth
- biotech investing
- Biotech investor
- Biotech IPO
- biotech jobs
- biotech news
- biotech patent news
- biotech revolution
- biotech salary
- Biotech Stock
- Biotech Venture Capital
- BiotechIT
- biotechnology
- biotechnology company
- Biotechnology Value Fund
- Biotectid
- Biotest
- Biothera
- BioThorpe
- Biotica Technology
- BioTie Therapies
- BioTime
- Biovail
- BiovaxID
- Biovest International
- BioVex
- Biovitrum
- BioWa
- BioXell
- BiPar Sciences
- Bipolar
- Bipolar disorder
- birth control
- BL-1040
- BLA
- Black Box Warning
- Bladder Cancer
- blinatumomab
- blockbusters
- blood cancer
- blood clots
- blood pressure
- blood substitute
- BN ImmunoTherapeutics
- boceprevir
- Boda
- Boehringer Ingelheim
- bone cancer
- Boostrix
- Bosatria
- Boston
- Boston Scientific
- Botox
- Bradley Pharma
- Bradmer Pharmaceuticals
- brain cancer
- brain disease
- BrainCells
- breast cancer
- Bremelanotide
- Brent Norton
- brentuximab vedotin
- Bridion
- Briggs Morrison
- Brilinta
- Bristol-Myers Squibb
- Broad Institute
- Bronchitol
- Brostallicin
- Bruce Boise
- Bryan Lawis
- Bryan Morton
- BSI-201
- BTG
- bucindolol
- Budesonide
- Buprenorphine
- Bush Administration
- business development
- Busulfex
- buyouts
- Bydureon
- Byetta
- C.R. Bard
- cabazitaxel
- Cadence Pharmaceuticals
- Cadila Healthcare
- Cadila Pharmaceuticals
- Calando Pharmaceuticals
- California
- California Institute for Regenerative Medicine
- Calistoga Pharmaceuticals
- Callisto Medical
- Cam Garner
- Cambria Biosciences
- Cambria Pharmaceuticals
- Cambridge
- cambridge antibody technology
- Cambridge Biotechnology
- Cambridge Company
- cambridge massachusetts
- Campath
- Can-Fite BioPharma
- Canaccord Capital
- Canada
- Cancer
- Cancer Drugs
- cancer pain
- cancer research
- Cancer Therapeutics CRC
- cancer therapies
- cancer vaccine
- Cancidas
- Cangene
- cangrelor
- Cannabinoids
- Canopus BioPharma
- capital partners
- Capoxigem
- Cara Therapeutics
- Caraco Pharmaceutical Laboratories
- Carbaglu
- Cardene
- Cardio3 BioSciences
- Cardiology
- Cardiome Pharma
- Cardiovascular Biotherapeutics
- cardiovascular risks
- Cariprazine
- Carisbamate
- Carl Icahn
- Carlo Paribello
- Carlos Paya
- Carol Gallagher
- Carrolee Barlow
- Cascade ProDrug
- case studies
- Castle Biosciences
- Catalent Pharma Solutions
- Catalyst Biosciences
- Catalyst Pharmaceutical
- Catapult Bio
- Catena
- Cato Research
- Cayston
- CD103
- CDC
- CDX-110
- Ceftaroline
- ceftobiprole
- Cel-Sci
- Celacade
- Celator Pharmaceuticals
- Celebrex
- Celera
- Celgene
- Cell Biosciences
- Cell Genesys
- Cell Therapeutics
- CellCentric
- CellCept
- CellCyte
- Celldex Therapeutics
- Cellerix
- cells
- Cellular Dynamics
- Cellzome
- Celsion
- Celtic Pharma
- Celtic Therapeutics
- CEM-101
- CEM-102
- Cempra Pharmaceuticals
- CeNeRx BioPharma
- Cenomed BioSciences
- Center for World Health & Medicine
- Centocor Ortho Biotech
- central nervous system
- CEP-37247
- Cephalon
- Ceplene
- Ception Therapeutics
- Cequent Pharmaceuticals
- Ceragenix Pharmaceuticals
- Cerenis Therapeutics
- Cerepro
- Ceres
- Cerexa
- Cerezyme
- Cerulean Pharma
- Cervarix
- cervical cancer
- cervical cancer vaccine
- cethromycin
- CETP inhibitors
- Cetrorelix
- CEVEC Pharmaceuticals
- CFO
- CG Therapeutics
- Chad Therapeutics
- Champions Biotechnology
- Chandrix
- Charles Baum
- Charles Butt
- Charles Grassley
- Charles River
- Chelsea Therapeutics
- ChemBridge
- ChemDiv
- ChemGenex
- ChemoCentryx
- Chemokine Therapeutics
- chemotherapy
- Chi-Med
- chief medical officer
- chief operating officer
- chief scientific officer
- Chiesi Farmaceutici
- Chile
- Chimerix
- China
- China Aoxing
- China Nuokang Bio-Pharmaceutical
- China Pharma Holdings
- China SFDA
- China SFDA approval
- China Sky One Medical
- China West
- Chinese Academy of Merical Sciences
- Chiron
- Chmp
- CHMP recommendation
- cholesterol
- cholesterol drug
- Chorus
- Chris Brinsmead
- Chris Newton
- Chris Viehbacher
- Christopher Spooner
- Christy Shaffer
- Chroma Therapeutics
- Chromatin
- Chromocell
- Chronic Idiopathic Constipation
- chronic lymphocytic leukemia
- Chugai
- Chutes and Ladders
- Cialis
- CIDP
- cilomilast
- Cimzia
- Cinquil
- Cinryze
- Cipher Pharmaceuticals
- Circassia
- CK-1827452
- CK-2017357
- cladribine
- claribine
- Claritin
- Clarus Ventures
- Class Action
- Clavis Pharma
- clean tech
- Cleveland Clinic
- Cleviprex
- clevudine
- Clinical Data
- Clinical Development
- Clinical Trial
- clinical trial design
- Clinical Trial Results
- ClinPhone
- Clive Dix
- Clolar
- cloning
- clostridium difficile
- Clovis Oncology
- Clyclacel
- CNTO 1275
- Coartem
- Coast IRB
- Codexis
- Cofactor
- Cogane
- Cogentus Pharmaceuticals
- Cognition Therapeutics
- Col-118
- Colazal
- Collaboration Agreement
- collaborations
- CollaGenex Pharmaceuticals
- CollaRx
- colon cancer
- Colorado
- colorectal cancer
- CoLucid Pharmaceuticals
- Columbia Laboratories
- Columbia University Medical Center
- combination
- Combinatorx
- combined company
- combo drug
- CoMentis
- commercialization
- Commercialization deals
- Commonwealth Biotechnologies
- competitors
- Complete Genomics
- Compugen
- Computer Model
- Conbriza
- Concert Pharmaceuticals
- Concordia Pharmaceuticals
- Conflict of interest
- Congress
- ConjuChem
- Connecticut
- Constellation Pharma
- construction
- contraceptive
- Contrave
- controversy
- Copaxone
- COPD
- CORDAPTIVE
- Cordex Pharma
- Cordis
- Coreg
- Corey Goodman
- Corgentech
- Coria Laboratories
- corifollitropin alfa
- Cork
- Cornerstone BioPharma
- Cornerstone Therapeutics
- Cortex Pharmaceutcials
- Corthera
- Corus Pharma
- CorVue
- Cotara
- Cougar Biotechnology
- counterfeit drugs
- Covance
- Covidien
- Cowen Healthcare Royalty Partners
- cox 2 inhibitor
- CP-4126
- CP-690
- CP-945598
- CPC Scientific
- CPEX Pharmaceuticals
- CPP-109
- CPX-351
- CR014
- Craig Tooman
- Crestor
- Critical Path Initiative
- Critical Pharmaceuticals
- critical therapeutics
- critics
- CRIX
- CRO
- Crohn's disease
- Crucell
- Cryo-Cell
- CRYSTAL study
- CrystalGenomics
- CSL
- CTEP inhibitors
- CU-2010
- Cubicin
- Cubist Pharmaceuticals
- Cumberland Pharmaceuticals
- Curacyte
- curagen
- Curis
- Curosurf
- Curt Selquist
- CV Therapeutics
- CVRx
- CX717
- Cyberkinetics
- cybrids
- Cyclacel
- Cyclofluidic
- Cycloset
- Cydex Pharmaceuticals
- Cylene Pharmaceuticals
- Cymbalta
- Cyntellect
- Cypress Bioscience
- cystic fibrosis
- CYT003-QbG10
- CYT006-AngQb
- CytImmune Sciences
- Cytochroma
- CytoDyn
- CytoFab
- Cytogen
- CytoGenix
- cytokinetics
- Cytolin
- Cytopia
- Cytos Biotechnology
- Cytovance Biologics
- CytRx
- Czech Republic
- d center
- dacetuzumab
- Dacogen
- Daiichi Sankyo
- Dainippon Sumitomo
- Dako
- dalbavancin
- Dan Dueber
- Danaher Corp
- Daniel Adams
- Daniel S. Goldberg
- Daniel Vasella
- Daniel Zurr
- Danisco BioActives
- dapagliflozin
- DAR-311
- DARA BioSciences
- Darmstadt Germany
- darusentan
- data monitoring committee
- David Baltimore
- David Brennan
- David Ebersman
- David Eveleth
- David Ginsberg
- David Heimbrook
- David Holveck
- David Hung
- David Mackney
- David Mazzo
- David Mott
- David Murdock
- David Pritchard
- David Schenkein
- DaVinci Biosciences
- Daxas
- Daytrana
- DBV Technologies
- Debio 025
- Debiopharm
- Debiovision
- Deciphera Pharmaceuticals
- Decode Genetics
- defibrotide
- deforolimus
- Degarelix
- Deirdre Connelly
- Delcath
- delisting
- Delsite
- Deltanoid
- Democrats
- Dendreon
- Dengue fever
- Denmark
- Denosumab
- Denver
- Department of Defense
- Department of Health and Human Services
- Department of Justice
- DepoDur
- Depomed
- depression
- Derica Rice
- DermaTech
- Desmoteplase
- Deval Patrick
- development costs
- Development deals
- Devgen
- DIA
- DIA 2009
- Diabetes
- diagnostics
- Diakron Pharmaceuticals
- Diasome Pharmaceuticals
- Diatos
- Dicerna Pharmaceuticals
- Difluprednate
- Dimebon
- Dimera
- DiObex
- Diractin
- Direvo Biotech
- dirucotide
- Disclosure
- Discovery Labs
- Distribution deal
- DNA Therapeutics
- doctors
- Domain Associates
- dopamine
- Dopexamine
- Dor BioPharma
- Doribax
- Douglas Squires
- Dov Pharmaceutical
- Dow Pharmaceutical Sciences
- Doxil
- DPP-4 inhibitors
- DR Cysteamine
- Dr. Reddy's
- Dr. Steven Nissen
- Draper Laborator
- Drew Faust
- Droxidopa
- Drug approvals
- drug candidates
- drug combination
- drug data
- drug delivery technology
- drug developer
- Drug Development
- Drug Discovery
- drug marketing
- drug prices
- Drug repositioning
- drug reprofiling
- Drug Resistance
- Drug Safety
- Drug Trials
- Drug-Induced Human Liver Injury
- DSM Biologics
- DTC advertising
- Duke University
- Duramed Pharmaceuticals
- Dusa Pharmaceuticals
- Duska Therapeutics
- dutogliptin
- DX-88
- Dyadic
- Dyax
- Dyloject
- Dynavax Technologies
- Dynogen
- dysmenorrheal
- Dysport
- E10030
- earnings
- Eastern Europe
- Ebola Hemorrhagic Fever
- ecallantide
- ECLIPSE study
- Economic development
- eculizumab
- EDEN Bioscience
- Edluar
- efalizumab
- efavirenx
- Effient
- EffRx
- Egg-based
- Eiger BioPharmaceuticals
- Eisai
- EKR Therapeutics
- elacytarabine
- Elafin
- Elan
- Elbion
- Election 2008
- elesclomol
- Eli and Edythe Broad
- Eli Lilly
- Elias Zerhouni
- Eligard
- elinogrel
- Elitra Pharmaceuticals
- Elixir Pharmaceuticals
- Elizabeth Dragon
- Elk Run
- Ellen McDonald
- Elliot Sigal
- ELND005
- elotuzumab
- Elton John
- Elusys Therapeutics
- Embeda
- embryonic stem cells
- EMD Serono
- EMEA
- EMEA application
- EMEA Approval
- EMEA recommendation
- Emergent BioSolutions
- Emerging Drug Developer
- emerging markets
- emerging outsourcing trends
- EmergingMed
- Emisphere
- EMO-FARM
- Empatic
- En Li
- Enbrel
- Encore Therapeutics
- Encorium Group
- Encysive
- Endeavor
- Endo Pharmaceuticals
- endometriosis
- Enlight Biosciences
- Enobia Pharma
- Ensemble Discovery
- Entelos
- Entereg
- EntreMed
- Entrepreneur
- EnVivo
- Envoy Therapeutics
- Enzo Biochem
- Enzon Pharmaceuticals
- Enzymatic Therapy
- Enzymotec
- Eon Labs
- Epeius Biotechnologies
- EpiCept
- EpiCeram
- epilepsy
- Epistem
- EPIX Pharmaceuticals
- Epizyme
- Epratuzumab
- Eprova
- Equasym
- equity investment
- Erbitux
- erectile dysfunction
- Eric Lander
- Erythema
- Erythropoietin
- ES Cell International
- ESBATech
- Esperion Therapeutics
- Esprit Pharma
- Esreboxetine
- Essentialis
- Essex Woodlands
- Eszopiclone
- etanercept
- Eugene Melnyk
- Eureka Genomics
- Europe
- European Commission
- EUSA Pharma
- EvaMist
- Evan Levine
- Everolimus
- Evista
- Evoke Pharma
- Evolva
- Evotec
- EVT 101
- EVT 103
- EVT 201
- EX101
- EXACT Sciences
- Exalgo
- Excalibur
- Excel PharmaStudies
- Executives
- Exelixis
- exenatide
- Exeter Life Sciences
- Eximias
- ExonHit Therapeutics
- Exparel
- Experimental Drugs
- experimental therapy
- expert advice
- Exubera
- EyeCyte
- Eyegate
- Eyetech
- f-star
- F2695
- Fablyn
- Fabrazyme
- Facet Biotech
- factive
- Faheem Hasnain
- Failed drug program
- fampridine
- Famvir
- Fanapt
- FASgen
- Fast Forward
- Fast Track designation
- Fate Therapeutics
- fatostatin
- Fauci
- Favrille
- FDA
- FDA application process
- FDA approvable letter
- FDA approval
- FDA approval & regulation
- FDA delay
- FDA investigation
- FDA priority review
- FDA quality certification
- FDA recommendation
- FDA regulation
- FDA rejection
- FDA response letter
- FDA review
- FDA update
- FDA warning
- federal funding
- federal judge
- female sexual dysfunction
- Femara
- FemiFect
- Fentora
- FermaVir
- Ferring Pharmaceuticals
- fertility
- ferumoxytol
- Fibromyalgia
- Fidia Farmaceutici
- FIELD study
- Fierce 15
- figitumumab
- Filgrastim
- financial reports
- finasteride
- Firebird
- FirstPoint Biotech
- Fisher Scientific
- Five Prime Therapeutics
- Flagship Ventures
- Flamel
- Flemming Lindeløv
- Flex Biomedical
- Flexion Therapeutics
- flibanserin
- Florida
- flu
- flu vaccine
- FluBlok
- Fluidigm
- Flumist
- Fluorotechnics
- Flurizan
- Flutiform
- FMD Report
- FoldRx Pharmaceuticals
- Follica
- Folotyn
- foot-and-mouth
- Foradil
- Forbes Medi-Tech
- Forest Laboratories
- Forma Therapeutics
- Formac Pharmaceuticals
- Formatech
- ForteBio
- Fortesta
- fospropofol disodium
- Foundation Medicine
- Fountain Healthcare Partners
- Fovea Pharmaceuticals
- Fragile X Research
- France
- France Biotech
- Francis Collins
- Frank Baldino
- Frank Callahan
- Franz Humer
- Fred Eshelman
- Fred Hassan
- Frova
- FT1050
- FTC
- FTY720
- funding
- funding gap
- Fusilev
- FV-100
- GA101
- Gabapentin GR
- Gabriel Sciences
- Galantamine Hydrobromide
- Galapagos
- Galderma
- Galenea
- Galenica
- galvus
- Gammagard
- Gamunex
- Ganymed Pharmaceuticals
- GAO
- Gardasil
- Garnet Biotherapeutics
- Garo Armen
- Garry Nicholson
- Gary Reys
- Gary Shearman
- gastroparesis
- Gattex
- GDC-0449
- GE
- Gedeon Richter
- gemcitabine
- Gemin X Pharmaceuticals
- Gen-Probe
- Genaera
- Genasense
- Gencaro
- Gene Logic
- gene targeting
- gene therapy
- Genelabs Technologies
- GeneNews
- Genentech
- general counsel
- General Electric
- GeneraMedix
- Generex
- Generic
- Generic Biologics
- Generics
- genes
- Genesis Pharmaceuticals
- GeneThera
- genetic model
- genetic test
- Genetically Engineered Animals
- genetics
- Genetix Pharmaceuticals
- GENFIT
- Genitope
- Genizon
- GenMab
- Genocea Biosciences
- GenoLogics
- Genome
- Genomic Health
- Genomic Vision
- Genomics
- GENova Biotherapeutics
- Genta
- Gentium
- Genvec
- Genway Biotech
- Genyous Biomed
- Genzyme
- GeoPharma
- George Church
- Georges Gemayel
- Georgia
- GeoVax
- Gerard Le Fur
- Gerard Martino
- Geron
- Gestiva
- GI-5005
- gifts
- Gilead Sciences
- Ginkgo Bioworks
- Gino Santini
- glaucoma
- GlaxoSmithKline
- Gleevec
- Glenmark Pharmaceuticals
- Glenn Gormley
- Glide Pharma
- globalization
- GlobeImmune
- Gloucester Pharmaceuticals
- GLPG0259
- GlycArt
- GlycoMimetics
- GlycoVaxyn
- Glyn Edwards
- GM Biopharmaceuticals
- going concern warning
- Goldmans Sachs
- Golimumab
- Google Ventures
- Gordon Brown
- Gordon Wier
- gout
- Gov. Christine Gregoire
- GPC Biotech
- GPCR
- Graceway Pharmaceuticals
- GRC 6211
- green initiatives
- Gregory Lucier
- GRNOPC1
- Grupo Ferrer
- GS 9191
- GS9411
- GSK1838262
- GTC Biotherapeutics
- GTCR Golder Rauner
- GTx
- GVAX immunotherapy
- GVK Biosciences
- GW Pharma
- GWAS
- Gwen Krivi
- Gyros
- H. Lundbeck
- H. Stewart Parker
- H1N1
- HAART
- HAE
- Haemacure
- Halo Pharmaceutical
- Halozyme
- Hana Biosciences
- Handok Pharmaceuticals
- Hank McKinnell
- Haptogen
- Harbor BioSciences
- Harold Varmus
- Harry Stylli
- Harvard
- Harvard Medical School
- Hawaii Biotech
- HBM Bioventures
- HCD122
- HCV NS5A
- HE3235
- head and neck cancer
- Head Lice
- Healive
- Health Canada
- Health Canada approval
- healthcare reform
- Healthcare Ventures
- HealthLinx
- heart disease
- heart drug
- Helical Sciences
- Helicon Therapeutics
- Helicos BioSciences
- Helix BioMedix
- Helix Biopharma
- Helixis
- Helmholtz Zentrum München
- Helsinn
- Hematide
- Hemispherx Biopharma
- Hemo-Stream
- hemophilia
- Hemopure
- Henri Termeer
- Henry E. Blair
- Henry Waxman
- Heparin
- Hepartes
- hepatitis B
- Hepatitis C
- Heplisav
- Hepregen
- Heptares Therapeutics
- Herceptin
- hereditary angieoedema
- Heritage Pharmaceuticals
- Hesperion
- High Throughput Genomics
- Hillary Clinton
- HIPAA
- Hirofumi Onosaka
- Hisamitsu Pharmaceutical
- Histogenics
- HIV/AIDS
- HIV/HBV
- Hodgkin's lymphoma
- Hollis-Eden Pharmaceuticals
- Horizant
- Horizon Therapeutics
- Hospira
- hostile takeover
- Hovione
- Howard Richman
- HPN-100
- HRA Pharma
- Hubert Birner
- Human African Tryanosomiasis
- Human Genetic Therapies
- Human Genome Sciences
- human growth hormone
- Humana
- Humanetics Corporation
- HuMax CD-20
- HuMax-EGFr
- Humira
- Huntingdon Life Sciences
- Huntington's
- HUYA Bioscience
- HVC-796
- Hwang Woo-suk
- hybrid
- Hycamtin
- Hydra Biosciences
- Hyperion Therapeutics
- hypertension
- hypoactive sexual desire disorder
- HZT-501
- Ian Garland
- iBioPharma
- Ibis Biosciences
- Ibis T5000
- IBM
- Ibraheem Mahmood
- ICA-105665
- Icagen
- iCardiac Technologies
- icatibant
- iclaprim
- ICON
- Iconix Biosciences
- IDEA
- Idenix Pharmaceuticals
- Idera
- Idera Pharmaceuticals
- IDM Pharma
- IDX899
- Ikano Therapeutics
- Ikaria
- Ikonisys
- Ilaris
- Illumina
- iloperidone
- Iluvien
- Ilypsa
- imaging
- ImaRX Therapeutics
- IMC-1121B
- IMC-11F8
- IMC-A12
- ImClone
- Imitrex
- Immtech Pharmaceuticals
- Immune Design
- immune response
- immune system
- Immuno-Designed Molecules
- ImmunoCellular Therapeutics
- Immunocore
- ImmunoGen
- Immunomedics
- Immunosyn
- ImmunoVaccine Technologies
- immununotherapy
- ImmuPharma
- IMO-2055
- IMPACT study
- IMPAX
- Impax Labs
- Implicit Bioscience
- IMS Health
- Imvamune
- INC Research
- INCB18424
- INCB28050
- INCB28060
- Incyte Corporation
- IND
- indacaterol
- Indevus Pharmaceuticals
- Index Ventures
- India
- indication
- IndiPharm
- Indonesia
- Industry Voices
- Inex Pharmaceuticals
- InfaCare Pharmaceutical
- infectious diseases
- Infinity Pharmaceuticals
- inflammatory conditions
- inflammatory diseases
- injectable
- InNexus Biotechnology
- Innocoll
- Innogenetics
- Innopharm
- Innovatis
- Innovative Medicines Initiative
- INNOVIVE Pharmaceuticals
- INO-4885
- INO-8875
- Inotek Pharmaceuticals
- Inovio
- InSite Vision
- Insmed
- insomnia
- Inspire Pharmaceuticals
- Instem
- insulin
- insurance companies
- INT-747
- INT-777
- Intanza
- Intas
- Integral Molecular
- Integrated Biopharma
- Integrated Biotherapeutics
- Intelect Medical
- Intelence
- Intellect Neurosciences
- Intelliject
- Intellikine
- Intercell
- Intercept Pharmaceuticals
- Intercytex
- Intermezzo
- Intermune
- International Stem Cell Corp
- Interphex
- Intertech Bio
- InterWest Partners
- Intra-Cellular Therapeutics
- Intradigm
- Intranasal Therapeutics
- Intrexon
- Introgen Therapeutics
- investigation
- investigators
- investment
- Inviragen
- Invitrogen
- Invus
- IoGen
- Iomai
- Iorcaserin
- IP
- IPI-493
- IPI-504
- IPI-926
- iPieran
- ipilimumab
- Iplex
- IPSC
- Ipsen
- Ipsogen
- Ireland
- IRES technology
- Iressa
- Ironwood Pharmaceuticals
- Irritable Bowel Syndrome
- isavuconazole
- Isconova
- Isentress
- ISIS 301012
- ISIS 388626
- Isis Pharmaceuticals
- Isolagen
- Isotechnika
- Israel
- ISTA Pharmaceuticls
- Istodax
- Itero Biopharmaceuticals
- ITI Life Sciences
- IXEMPRA
- iZumi Bio
- J. Craig Venter
- J. Michael Pearson
- Jack Lief
- JADO Technologies
- James Bianco
- James Cornelius
- James Mullen
- James S. Kuo
- James Shannon
- James White
- Jan Lundberg
- Janssen
- Janumet
- Januvia
- Japan
- Japan Tobacco
- jassen
- Javelin Pharmaceuticals
- Javier San Martin
- Jazz Pharmaceuticals
- Jérôme Contamine
- JDS Pharmaceuticals
- Jean Stéphenne
- Jean-Claude Leroy
- Jean-Luc Belingard
- Jean-Marc Huet
- Jean-Pierre Garnier
- Jeffrey H. Buchalter
- Jeffrey Kindler
- Jennerex
- Jerini
- Jerusalem
- Jexys Pharmaceuticals
- JHP Pharmaceuticals
- Jiangbo Pharmaceuticals
- Jim Kerstetter
- JLL Partners
- job cuts
- Joe Bolen
- Joe Jimenez
- Joel Lexchin
- John Babich
- John C. Martin
- John Dyer
- John Johnson
- John Knopf
- John LaForge
- John LaMattina
- John Lechleiter
- John Maraganore
- John McCain
- John Milligan
- John Oyler
- John P. Longenecker
- John P. Walker
- John Patterson
- Johns Hopkins
- Johnson & Johnson
- Jolee Mohr
- Jon P. Stonehouse
- Jon Symonds
- Joseph Yanchik
- Joshua Boger
- Joshua Sharfstein
- Journal of the American Medical Association
- JTT-305
- Jubilant Biosys
- Juergen Ernst
- JUPITER study
- Justiva
- Juvaris BioTherapeutics
- JVRS-100
- JZP-4
- JZP-6
- JZP-7
- K-RAS gene
- Kadmon I LLC
- KAI Pharmaceuticals
- KAI-9803
- Kalbitor
- Kalgene Pharmaceuticals
- KaloBios
- Kalypsys
- Kamada
- Kansas
- Kansas Bioscience Authority
- Kari Stefánsson
- Karl Ludwig Kley
- Karo Bio
- KB2115
- Keith Carter
- Keith Leonard
- Kelly Martin
- Kemin Pharma
- Ken Bate
- Kendle International
- Kenta Biotech
- Keppra
- Kereos
- Keryx Biopharmaceuticals
- Ketek
- Kevin Judice
- Kevin Sharer
- Kiadis Pharma
- kidney cancer
- kidney disease
- kinase
- King Pharmaceuticals
- Kingsbridge Capital
- Kirsten Drejer
- Kleanthis Xanthopoulos
- Kleiner Perkins Caufield & Byers
- Knome
- Knopp Neurosciences
- Kogenate
- Kohl
- Kolltan Pharmaceuticals
- Konrad Hochedlinger
- Kos Parmaceuticals
- Kotinos Pharmaceuticals
- Kotra Pharma
- Kowa
- KRX-0401
- Krystexxa
- Kuvan
- KV Pharmaceutical
- Kynapid
- Kyowa Hakko
- Kyphon
- Kythera Biopharmaceuticals
- L. Patrick Gage
- La Jolla Pharmaceutical
- LabCorp
- Labopharm
- Lacosamide
- Langdon Miller
- Laninamivir
- Lannett
- lansoprazole
- Larry Goldstein
- Latin America
- Latisse
- Laurie Halloran
- Lawrence Bloch
- Lawrence Tamarkin
- lawsuits
- layoffs
- LCZ696
- LEAD Therapeutics
- Leerink Swann
- legislation
- Lehman Brothers
- Leo Pharma
- Leslie Browne
- Letairis
- leukemia
- Lev Pharmaceuticals
- Levadex
- Levaquin
- Levemir
- Levitra
- Lexapro
- Lexicon
- Lexicon Pharmaceuticals
- Lexiscan
- LFB Technologies
- LGD-4665
- LibiGel
- Licensing deals
- Life Science Pharmaceuticals
- Life Technologies
- Ligand Pharmaceuticals
- Light Sciences Oncology
- LigoCyte Pharmaceuticals
- Ligon Discovery
- Limerick BioPharma
- Linaclotide
- linagliptin
- LineaGen
- Link Medicine
- Linkage Biosciences
- Lipid Sciences
- Lipitor
- liprotamase
- liquidation
- Liraglutide
- Lithium QD
- Liver
- liver cancer
- Living Cell Technologies
- Lobbying
- Lodotra
- Longevity
- Lonza Group
- Loramyc
- lorcaserin
- Lovenox
- LSP
- LTX-109
- LTX-315
- Lu AA21004
- Lucentis
- Lumavita
- Lumigan
- Lumizyme
- Luna Innovations
- Lundbeck
- lung cancer
- Lunivia
- Lupin
- lupus
- Lupus Nephritis
- lurasidine
- lurasidone
- Lusedra
- Lux Biosciences
- LX4211
- LX6171
- LXR-623
- LY156735
- LY2140023
- Lycera
- lymphoma
- Lytix Biopharma
- MabCure
- MabThera
- MacroChem
- MacroGenics
- MacroGenitcs
- Macugen
- macular degeneration
- major depressive disorder
- major market trends
- malaria
- Malaysia
- Malcolm Weir
- Malvinder Mohan Singh
- MammaPrint
- Mannkind
- manufacturing
- Manufacturing deal
- MAP Pharmaceuticals
- Mapatumumab
- Marburg Fever
- Margaret Hamburg
- maribavir
- Marijn Dekkers
- Marinus Pharmaceuticals
- Mario Capecchi
- Mark Heesen
- Mark J. Fitzpatrick
- Mark Levin
- Mark McDade
- market access strategies
- Martin Evans
- Martin Mackay
- Martin Madaus
- Martin Mattingly
- Martin O'Malley
- Martin Simonetti
- Maryland
- Mass Medical Angels
- Massachusetts
- Massachusetts Biologic Laboratory
- Massachusetts Biotechnology Council
- Massachusetts Building Trade Council
- Matrix Laboratories
- Matt Emmens
- Matt Winkler
- Matthew Pfeffer
- Matuzumab
- maximize
- Maxy-4
- MAXY-alpha
- MAXY-G34
- Maxygen
- Mayne Pharma
- Mayo Clinic
- Mayo Clinical Trial Services
- MBP8298
- McGill University
- McNeil
- MDRNA
- MDS
- MDS Analytical Technologies
- MDV3100
- MDX-1100
- MDX-1106
- Meda
- Medarex
- Medgenics
- Medicago
- Medical device
- Medicare
- MediciNova
- Medicis
- Medicure
- Medigen
- MediGene
- Medimetriks Pharmaceuticals
- MedImmune
- MediQuest Therapeutics
- Meditrina
- Medivation
- Medivir
- Medtronic
- Melanoma
- Melphalan
- MEM 3454
- Memory Pharmaceuticals
- meningitis
- Menopause
- Menveo
- Mepact
- mepolizumab
- Merck
- Merck BioVentures
- Merck KgAA
- Merck Serono
- Mercury Therapeutics
- Mergers and Acquisitions
- Merial Animal Health
- Merlin Biosciences
- Merrimack Pharmaceuticals
- Merrion
- Merus
- Mesafem
- MET inhibition
- Metabasis Therapeutics
- Metabolic disorders
- Metabolic Solutions Development
- Metabolon
- Metastasis
- Metastatix
- MethylGene
- Metozolv
- Mexico
- MF59
- MFAH
- MGCD0103
- MGI Pharma
- Michael Loberg
- Michelle Chang
- Michigan
- Microbia
- MicroIslet
- Micromet
- microplasmin
- microRNA
- Middle East
- MiddleBrook Pharmaceuticals
- mifamurtide
- Migenix
- migraine
- Mikael Dolsten
- Mike Bonney
- Mike Leavitt
- Mike Varney
- Miles White
- milestones
- Millennium Pharmaceuticals
- Millipore
- Minnesota
- minorities
- Minster Pharmaceuticals
- mipomersen
- Miragen Therapeutics
- Mircera
- Mirina Corporation
- miRNA
- Mirus
- Mistral Pharma
- MIT
- Mitsubishi Tanabe Pharma
- MK-0524A
- MK-2206
- MK-677
- MK-7009
- Moberg Derma
- Molecular Biometrics
- molecular diagnostics
- Molecular Insight Pharmaceuticals
- molecules
- Momenta Pharmaceuticals
- Moncef Slaoui
- monoclonal antibody
- MonoGen
- Monogram Biosciences
- Monovisc
- Monsanto
- Moraga
- MorphoSys
- Morphotek
- Morvus
- motavizumab
- motesanib
- Motivizumab
- Movetis
- Moxifloxacin
- Mozobil
- Mpex Pharmaceuticals
- MPM BioVentures
- MPM Capital
- MRSA
- MSX-122
- Multaq
- multikine
- multiple myeloma
- multiple sclerosis
- Mundipharma
- Muscular Dystrophy
- Myasthenia Gravis
- Myelodysplastic Syndromes
- myeloma
- Mylan Laboratories
- Mylan Pharmaceuticals
- Mymetics
- Myogen
- Myozyme
- Myriad Genetics
- Myriad Pharmaceuticals
- Nabi Biopharmaceuticals
- Nabriva Therapeutics
- Nancy Wexler
- Nanobac Pharmaceuticals
- NanoBio Corp.
- Nanobody
- Nanogen
- Nanosphere
- NanoString Technologies
- nanotechnology
- NanoTherapies
- naproxcinod
- naproxen
- nasal spray
- Nastech
- Nat Ricciardi
- Natco Pharma
- National Cancer Institute
- National Institutes of Health
- natrecor
- Naturlose
- Navigenics
- NCX 116
- Nebido
- Needle Insertion
- Neil Gibson
- Nektar Therapeutics
- NeoGenomics
- Neopharm
- neoprobe
- Neose Technologies
- Neostem
- Neovacs
- Neratinib
- Nereus Pharmaceuticals
- Nerviano
- Neuera Pharmaceuticals
- Neumune
- Neupro
- Neuradiab
- Neuralgia
- Neuralstem
- Neuraltus Pharmaceuticals
- NeurAxon
- Neurimmune
- Neuro-Hitech
- Neuro3d
- Neurobiological Technologies
- Neurochem
- neurocrine biosciences
- Neurogen
- NeurogesX
- Neuromed
- neuropathic pain
- Neuropharm
- Neuroptix
- NeuroScience Pharmaceuticals
- NeuroSearch
- Neurotech
- NeuroVax
- Neuvenge
- new blood
- New Drug Application
- New Drugs
- New England Journal of Medicine
- New Enterprise Associates
- New Jersey
- New Molecular Entity
- New York
- NewLink Genetics
- Newron
- newsday
- Nexavar
- NexBio
- Nexium
- NexMed
- NextBio
- nexterone
- NGM Biopharmaceuticals
- NGX-1998
- NGX-4010
- NGX267
- NGX426
- NI-0401
- NI-0501
- Niacin
- NIC002
- NIC5-15
- NICE
- Nicholas Piramal
- Nicholas Stergis
- Nick Seay
- NiCox
- NicVAX
- Niemann-Pick type C disease
- Nile Therapeutics
- nimotuzumab
- Nissan Chemical Industries
- Nitec Pharma
- Nitromed
- NixOx
- NKT Therapeutics
- NKTR-102
- NM100060
- NME approvals
- NMED-1077
- nNOS inhibitor
- Nobel Prize
- Nobilon
- Noel Doheny
- Nomad Bioscience
- non-Hodgkin's lymphoma
- non-small cell lung cancer
- Nonprofit
- NormOxys
- North Carolina
- North Shore Life Sciences Accelerator
- Northfield Laboratories
- Northstar Neuroscience
- Northwest Biotherapeutics
- Northwick Park
- Norway
- Nostrum Pharmaceuticals
- NovaBay Pharmaceuticals
- Novacea
- Novacta Biosystems
- NovaDel
- Novagali
- Novalar Pharmaceuticals
- Novartis
- Novavax
- Novelos
- Noven Pharmaceuticals
- Novexel
- NovImmune
- Novo Nordisk
- Novocell
- Novogen
- NovoSeven
- Novosom
- Novozymes
- NPL-2008
- Nplate
- NPS Pharmaceuticals
- NTC-801
- NUCRYST Pharmaceuticals
- Numerate
- Nuon Therapeutics
- Nupathe
- Nuren Pharmaceuticals
- Nutra Pharm
- Nuvelo
- Nuvigil
- Nuvion
- Nuvo
- Nuvo Research
- NVA237
- NVCA
- Nventa
- NX-1207
- NXL103
- NXL104
- NXN-188
- Nycomed
- Nymox
- Obama Administration
- obesity
- obsessive-compulsive disorder
- OccuLogix
- Oceana Therapeutics
- Ocera Therapeutics
- ocrelizumab
- OctoPlus
- Oculus Innovative Sciences
- Odanacatib
- ofatumumab
- offshore outsourcing
- Ofirmev
- oglemilast
- OGX-011
- olaparib
- Oligomerix
- Oliver Smithies
- Olympus Life Sciences
- Omacetaxine
- omacetaxine mepesuccinate
- Omeros
- Omigard
- Omni International
- Omnitura Therapeutics
- OMP- 21M18
- Omrix Biopharmaceuticals
- On the Radar
- Oncalis
- Oncoceutics
- OncoGenex
- Oncolin Therapeutics
- Oncology
- OncoMed Pharmaceuticals
- OncoMethylome
- Onconova Therapeutics
- Oncophage
- Oncoscience
- Oncothyreon
- OncoVex
- Onexa
- Onglyza
- Ono Pharmaceutical
- onrigin
- Ontaril
- Ontario
- Onyx Pharmaceuticals
- Opana
- Opaxio
- operations suspension
- Opexa
- OpGen
- Ophthotech
- Opioid Analgestic
- opioid-induced bowel dysfunction
- Opko
- OpRA III
- Opsona Therapeutics
- OPT-80
- Optherion
- optimal pricing
- Optimata
- Optimer Pharmaceuticals
- Oracea
- Oracle
- Oragenics
- Oraya Therapeutics
- orBec
- Orchestra Therapeutics
- Orchid Cellmark
- Orchid Chemicals
- Orexigen Therapeutics
- Orexin
- Orexo
- Organogenesis
- Organon
- Origen Therapeutics
- OriGene Technologies
- Origenis
- Orion
- Oritavancin
- orlistat
- orphan drug status
- Orphan Europe
- Orphan Status
- Ortho Biotech
- Ortho-McNeil
- Orthos Europe
- Oscient Pharmaceuticals
- OSI Pharmaceuticals
- Osiris Therapeutics
- Osmotica
- Osprey Pharmaceuticals
- Ostarine
- osteoarthritis
- Osteologix
- osteoporosis
- otamixaba
- OTC drugs
- Otsuka Pharmaceuticals
- outbreak
- outsourcing
- Outsourcing Deals
- ovarian cancer
- Ovation Pharmaceuticals
- OX914
- Oxagen Limited
- Oxford BioMedica
- Oxford Bioscience Partners
- Oxford Biotherapeutics
- Oxford Nanopore
- Oxford University
- OXiGENE
- Oxo International
- OXY11A
- Oxycontin
- Oxycyte
- Oxygen Biotherapeutics
- oxyrens
- Oxytrol
- ozarelix
- p53 biomarker
- Pacgen Biopharmaceuticals
- Pacific Biosciences
- Pacira Pharmaceuticals
- Paclitaxel
- pagoclone
- Pain Therapeutics
- pain therapy
- painkiller
- Paion
- Paladin Labs
- Palatin Technologies
- Palladia
- Palo Alto
- Panacea Biotec
- Panacos
- pancreatic cancer
- pandemic
- pandemic flu
- Pandemic Influenza
- PanGenetics
- Panomics
- Paoin
- Paolo Paoletti
- Par Pharmaceutical
- Paratek Pharmaceuticals
- Parexel
- Parion Sciences
- Parkinson's
- PARP inhibitor
- partnership
- Partnerships CROs
- Pascal Soriot
- patent
- patent application
- patent approval
- Patent challenge
- patent expiration
- Patent infringement
- patent lawsuit
- Patent news
- patent rules
- Patheon
- Pathway Therapeutics
- patient recruitment
- PatientKeeper
- Patrick Mahaffy
- Patrick Vallance
- Patrik De Haes
- Paul Bisaro
- Paul Capital Healthcare
- Paul Desjourdy
- Paul Greengard
- Paul Herrling
- Paul Maeder
- Paul Rubin
- Paul Touhey
- pazopanib
- PBMs
- PCK3145
- PDI
- PDL BioPharma
- PDL241
- PDS Biotechnology
- PDUFA
- Pearl Therapeutics
- PecFent
- Pediapharm
- Pegasus Biologics
- Pegasys
- Pegintron
- Peking University
- Pennsaid
- Pennsylvania
- PentaStaph
- Penwest Pharmaceuticals
- Peplin
- peptide
- Peptimmune
- Peramivir
- Perampanel
- Percivia
- Peregrine
- Perifosine
- Perkinelmer
- Perlegen
- Perlegen Sciences
- Perrigo
- personalized medicine
- Pervasis Therapeutics
- Peter Fellner
- Peter Kim
- Peter M. Hecht
- Peter Meldrum
- Peter Mueller
- Pevion Biotech
- PF-03187207
- Pfenex
- Pfizer
- Pfizer Global Research
- PG110
- Pharma Genexx
- Pharma news
- Pharmacells
- pharmaceutical companies
- pharmaceutical company
- pharmaceutical industry
- pharmaceutical outsourcing
- pharmaceuticals
- Pharmacopeia
- pharmacovigilance
- Pharmacyclics
- PharmaNet
- PharmaNet Development Group
- Pharmasset
- Pharmatech
- Pharmatech Oncology
- Pharmathene
- Pharmaxis
- PharmEng
- Pharmexa
- Pharming
- Pharmion
- Pharmos
- Pharnext
- Pharsight
- Phase 2 Discovery
- Phase I
- Phase II
- Phase III
- Phase IV
- PhaseBio Pharmaceuticals
- Phenomix Corporation
- phenoxodiol
- Philanthropy
- Philip Astley-Sparke
- Phillipe Archinard
- Phoenix
- PhRMA
- PHX1149
- physicians
- Phytopharm
- PI-88
- PI3-K
- Picoplatin
- Piedmont Pharmaceuticals
- Pieris
- Pierre Fabre Medicament
- Pill-Plus
- pimavanserin
- Pioneer
- pipeline
- Pipex
- Pique Therapeutics
- Piramed
- Pirbright
- pirfenidone
- Pittsburgh Center for Vaccine Research
- Pittsburgh Life Sciences Greenhouse
- Pivotal BioSciences
- Pixantrone
- PixelEXX Systems
- Pixuvri
- PL-100
- placebo effect
- Plan B
- Plavix
- Plethora Solutions
- Plexxikon
- Plicera
- Pliva
- PMA
- PML
- PN 400
- PN2034
- PN400
- Point Biomedical
- Point Therapeutics
- Polaris Venture Partners
- polyheme
- PolyMedix
- Polymer Technology Group
- Polyphor
- Poniard
- Poniard Pharmaceuticals
- Portola Pharmaceuticals
- Postherpetic Neuralgia
- POT-4
- Potelligent Technology
- Potentia Pharmaceuticals
- Pozen
- PPD
- PR0015
- Pradaxa
- pralatrexate
- pramiconazole
- Prana
- prasugrel
- Precedex
- Precision Therapeutics
- preclinical
- Precyse Solutions
- Predictive Biosciences
- pregabalin
- PregLem
- PreMD
- Presidio Pharmaceuticals
- Pressure BioSciences
- Prestwick Pharmaceuticals
- Prevacid
- Prevalere
- Prevnar
- Prevnar 13
- Prexige
- Prezista
- PricewaterhouseCoopers
- pricing
- Primary Immune Deficiencies
- Primera Biosystems
- priority
- Prism Pharmaceuticals
- Pristiq
- Private Equity
- private placement
- Privigen
- PRM-151
- PRO 2000
- Pro-Pharmaceuticals
- Proaegis Biosciences
- Probiodrug
- Probuphine
- Prochymal
- Procter & Gamble
- product portfolio
- proellex
- Profex
- ProFibrix
- profits
- Progen Pharmaceuticals
- Progenics Pharmaceuticals
- Project BioShield
- Project Boss
- Prolexys Pharmaceuticals
- Prolia
- Promacta
- Promedior
- ProMetic Life Sciences
- Promosome
- ProSavin
- Prosensa
- Prostate Biomarkers
- Prostate Cancer
- ProStrakan
- Prostvac
- ProtAffin
- Protalix
- protein
- Protein Sciences
- Proteo Biotech
- Proteolix
- Proteome Systems
- Proteon Therapeutics
- ProteoStasis Therapeutics
- Proteros biostructures
- Proteus Biomedical
- Protez Pharmaceuticals
- Protherics
- Protiva
- Protonix
- Protox Therapeutics
- Provectus Pharmaceuticals
- Provenge
- Provigil
- Proximagen Neuroscience
- PRT-201
- Prulifloxacin
- PRX302
- PS433540
- pSivida
- psoriasis
- Psyadon Pharmaceuticals
- PTC Therapeutics
- PTC124
- PTI-721
- PTK 0796
- public offering
- public trust
- Pulmatrix
- pulmonary arterial hypertension
- Pulmonary Disease
- Purdue Pharma
- PURE Bioscience
- PureTech Ventures
- PX-478
- PX-866
- PZ-601
- Q Therapeutics
- Q&A
- Q-Med
- QAB140
- QAB149
- Qiagen
- Qlaira
- QLT
- Qnexa
- QR Pharma
- QRxPharma
- Quaker Bioventures
- Quarfloxin
- Quark Pharmaceuticals
- QuatRx Pharmaceuticals
- Quebec
- Quest Diagnostics
- Questcor
- Quintiles
- QureInvest
- Qutenza
- Qwell Pharmaceuticals
- R&D budget
- R&D spending
- R7025
- R788
- RAD001
- radezolid
- Radius Health
- Raloxifene
- Ranbaxy
- Rapaflo
- Raptiva
- Raptor Pharmaceutical
- rare diseases
- Rasilez
- Ratiopharm
- Raven Biotechnologies
- raxibacumab
- Raymond Warrell
- Raymond Woosley
- Razadyne
- ReachBio
- Reagan-Udall Foundation
- Reata Pharmaceuticals
- Rebamipide
- Rebetol
- Rebif
- recall
- Recentin
- ReceptoPharm
- Receptor BioLogix
- Receptos
- Recession
- Reclast
- Recordati
- Red Cross
- Redpoint Bio
- Regado Biosciences
- regeneration
- regenerative medicine
- Regeneron Pharmaceuticals
- RegeneRx
- Regenesis
- Regulation
- Regulators
- regulatory affairs
- Regulus Therapeutics
- REIMBURSEMENT
- reimportation
- release formulation
- relenza
- ReliaGene
- Reliant Pharmaceuticals
- Relistor
- Reloxin
- Relsys International
- Relypsa
- Rember
- Remicade
- Remodulin
- Remoxy
- Remune
- ReN001
- Renagel
- renal cell carcinoma
- ReNeuron
- Renovis
- Renovo
- Replidyne
- Repligen
- Repros
- Republicans
- Resignation
- Resolvyx Pharmaceuticals
- respiratory diseases
- Response
- Restless Legs Syndrome
- Restructure
- restructuring
- resveratrol
- Resverlogix
- Retaane
- Retavase
- retention bonus
- retigabine
- REVA Medical
- Revance Therapeutics
- reverse merger
- Revlimid
- Revotar Biopharmaceuticals
- Rexahn Pharmaceuticals
- Rexin-G
- Reyataz
- Rezonic
- RGH-188
- RGN-259
- RHEI Pharmaceuticals
- Rheoscience
- Rheumatoid Arthritis
- rheumatology
- rhFIB
- Rhode Island
- Rhucin
- RhuDex
- Rhythm Pharma
- Riastap
- Rib-X Pharmaceuticals
- Ricerca Biosciences
- Richard Garr
- Richard Gold
- Richard Hollis
- Richard Jones
- Richard Klein
- Richard Scheller
- Richard Selden
- Richter-Helm BioLogics
- Rick Winningham
- rifaximin
- Rigel Pharmaceuticals
- Rinat Neuroscience
- Riquent
- RISPERDAL
- Ritalin
- Ritonavir
- Rituxan
- rivaroxaban
- RLIP76
- RNAi
- RoActemra
- Robert Califf
- Robert Coughlin
- Robert Coury
- Robert Langer
- Robert Sobol
- Roch Doliveux
- Roche
- Rockwell Medical
- Roger Newton
- Roger Tung
- rolofylline
- Romiplostim
- Ronacalaret
- Ronald Berninger
- Rosetta Genomics
- rotateq
- ROVI
- Royal DSM
- royalty payments
- RP101
- RT002
- RTA 402
- Russell Greig
- Russell Herndon
- Russell Medford
- Russia
- RVX-208
- RXi Pharmaceuticals
- s sales
- S*BIO
- Sabril
- safety data
- safety profile
- Sagent Pharmaceuticals
- Saladax Biomedical
- salary reduction
- sales and marketing
- Salix Pharmaceuticals
- Sam Waksal
- Samaritan Pharmaceuticals
- Samuel Saks
- San Diego
- San Francisco
- San Francisco Chronicle
- Sancuso
- Sanderling Ventures
- Sandoz
- Sangamo BioSciences
- Sangart
- Sanjay Kaul
- Sanofi Pasteur
- Sanofi-Aventis
- Santaris Pharma
- Santarus
- Santen Pharmaceutical
- Santhera
- SantoSolve
- Sapacitabine
- Saphris
- Sareum
- Sars
- Sartor
- Sartorius Stedim
- Sativex
- Satori Pharmaceuticals
- satraplatin
- SATURN study
- Savara Pharmaceuticals
- savella
- Savient Pharmaceuticals
- saxagliptin
- SB-509
- SB1317
- SB1518
- SB1578
- SB939
- sBLA
- SC4SM
- scarring
- Schering-Plough
- schizophrenia
- schizophrenia drug
- Schwabe Pharmaceuticals
- Schwarz BioSciences
- Schwarz Pharma
- SciClone
- Sciele Pharma
- science
- Scil Technology
- Scleroderma
- sclerosis drug
- SCOLR Pharma
- Scotland
- Scripps Research Institute
- Seahorse Bioscience
- Seaside Therapeutics
- Seattle
- Seattle Genetics
- Seattle Times
- SEC
- second half
- Second Quarter
- Selecta Biosciences
- Selzentry
- SemBioSys
- Seminar
- Senesco Technologies
- senicapoc
- SensiGen
- Sensipar
- SEP-225289
- Sepracor
- sepsis
- Sequel Pharmaceuticals
- Sequella
- sequencing
- Sequenom
- SER-3
- Serada
- Serdolect
- Serentis
- Serenx
- Serevent
- series c
- Sermo
- Sernova
- Serono
- Seroquel
- Severin Schwan
- SFJ Pharmaceuticals
- SGN-35
- SGN-40
- SGX pharmaceuticals
- Shantha Biotech
- Shareholder Activists
- shareholder lawsuits
- shareholders
- Sharklet Technologies
- Shenzhen Neptunus
- Sheri McCoy
- Shionogi
- Shire Pharmaceuticals
- sickle cell
- Sidney Taurel
- Sierra Neuropharmaceuticals
- Siga Technologies
- Sigma-Aldrich
- Sigma-Tau
- Sijmen de Vries
- Silence Therapeutics
- Silenor
- Simbionix
- Simcere
- Simcyp
- Simponi
- Sinclair Pharma
- Singapore
- Singulair
- Singulex
- SingVax
- Sinovac Beijing
- Sinovac Biotech
- Sir Christopher Evans
- Sirion Therapeutics
- Siritis Pharmaceuticals
- Sirna Therapeutics
- Sirtris Pharmaceuticals
- Skelaxin
- skin cancer
- skin infections
- Sky One Medical
- SkyePharma
- Slate Pharmaceuticals
- small business
- small molecules
- Smallpox
- smoking cessation
- SNS-595
- Social Media
- sofinnova ventures
- Sol Barer
- Solace Pharmaceuticals
- Soliris
- Solodyn
- Solvay Pharmaceuticals
- Solzira
- SOMA
- Somatuline
- Somaxon
- Somnus Therapeutics
- Sonexa Therapeutics
- Sonus Pharmaceuticals
- Sopherion Therapeutics
- Sosei
- South Africa
- South Carolina
- South San Francisco
- SP-6300
- Spain
- Specialized Therapeutics
- specialty drugs
- Spectrum Pharmaceuticals
- Speedel
- SpePharm Holding
- Spheramine
- Spherix
- spin-off
- Spinal Concepts
- Spine Wave
- spur
- SSRI
- St. Jude Medical
- St. Louis
- STA-4783
- STA-9090
- Stabilitech
- Stanley Erck
- Staph Leavenworth Bakali
- Start Licensing
- start-up
- Stason Pharmaceuticals
- statins
- Stedivaze
- Stem cell research
- Stem Cell Sciences
- Stem Cell Therapeutics
- Stem cells
- StemCells Inc.
- stents
- Stephen Ferruolo
- Stephen Seiler
- Stephen Simes
- Steve Hartig
- Steve Worland
- Steven Burrill
- Steven Engle
- Steven F. Goldstone
- Steven Kriegsman
- Stiefel Laboratories
- Stimuvax
- strain
- strategy
- Strativa Pharmaceuticals
- Strattera
- stroke
- Stromedix
- Stuart Peltz
- Sucampo
- sugammadex
- Sumavel
- Summit Corporation
- Sun Pharmaceuticals
- Sunesis Pharmaceuticals
- Suntron
- SuperGen
- Supernus
- Surface Logix
- Surfaxin
- SurModics
- Susan Desmond-Hellmann
- Sutro Biopharma
- SV Life Sciences Advisers
- Sweden
- Swedish Orphan
- Swedish Orphan Biovitrum
- swine flu
- Swiss Pharma Contract
- Switzerland
- Sygnis Pharma
- Symbicort
- Symbollon
- Symphogen
- Symphony GenIsis
- Symyx Technologies
- Synageva BioPharma
- Synavive
- Syncria
- Syngene
- Syngenta
- Synosia Therapeutics
- Synta Pharmaceuticals
- Syntaxin
- Synthetic biology
- Synvisc-One
- Synvista Therapeutics
- Systems Medicine
- T-DM1
- TachoSil
- Tadalafil
- TaiGen Biotechnology
- Taiwan
- TAK-390MR
- TAK-475
- Takeda
- Talabostat
- Talecris Biotherapeutics
- Tamibarotene
- Tamiflu
- tanezumab
- Tanox
- taranabant
- Tarceva
- Targacept
- Targanta Therapeutics
- Targeted Genetics
- Targeted Molecular Diagnostics
- Taribavirin
- Taris Biomedical
- Taro Pharmaceuticals
- Tarsa Therapeutics
- Tasigna
- tasimelteon
- taspoglutide
- TauRx Therapeutics
- TauTaTis
- Taxotere
- Taxus
- TB-403
- TC-2696
- TC-5214
- TC-6499
- Tecarfarin
- technology
- Technosphere
- Technosphere Insulin
- Teijin Pharma
- Teikoku Pharma
- Tekmira
- Tekturna
- telaprevir
- Telavancin
- telcagepant
- Telik
- Telormedix
- Tempero Pharmaceuticals
- tender offer
- Tengion
- teplizumab
- Terapio
- Tercica
- Terry Hisey
- Terry McGuire
- tesamorelin
- Tesetaxel
- tesofensine
- Tethys Bioscience
- Tetraphase Pharmaceuticals
- Teva Parental Medicines
- Teva Pharmaceutical Industries
- Texas
- Texas A&M
- tezampanel
- TG4010
- tgAAC94
- Thallion Pharmaceuticals
- The Bill & Melinda Gates Foundation
- The Medicines Company
- Thelin
- Theraclone Sciences
- Therasis
- Theratechnologies
- Theravance
- Therion Biologics
- Thermo Fisher
- ThermoGenesis
- Theron Odlaug
- Thiakis
- Third Point
- Third Rock Ventures
- Third Round
- Thomas A. Waltz
- Thomas Bigger
- Thomas Finneran
- Thomas Harlan
- Thomas J. Spencer
- Thomas Struengmann
- Threshold Pharmaceuticals
- Thrombin
- thrombocytopenia
- ThromboGenics
- Thrombosis
- thymalfasin
- Tibotec
- ticagrelor
- Tigris Pharmaceutical
- Tikvah Therapeutics
- Tim Noyes
- Timothy C. Rodell
- Tioga Pharmaceuticals
- TIPO-1
- Titan Pharmaceuticals
- TKS1225
- TLN-232
- TNFerade
- Tobacco
- Tocosol Paclitaxel
- Tocris
- TOK-001
- Tokai Pharmaceuticals
- Tolera Therapeutics
- Tolerx
- Tolmar Holdings
- Tom Watkins
- tonabersat
- Top 5
- Topaz Pharmaceuticals
- Topigen Pharmaceuticals
- Topiramate
- Topogen
- Torcetrapib
- Torisel
- TorreyPines Therapeutics
- Tovaxin
- Toviaz
- Tracking Stocks
- Traditional medicine
- Tragara Pharmaceuticals
- Tramadol
- Transave
- Transcend Medical
- Transcept Pharmaceuticals
- Transgene
- Transgeneron Therapeutics
- Transgenics
- Transition Therapeutics
- Transkaryotic Therapies
- translational research
- TransMolecular
- transparency
- TransPharma
- Tranzyme Pharma
- Trasylol
- Tredaptive
- Trellis Biosciences
- tremelimumab
- trends
- Trevor Mundel
- trial safety
- Trident Biotech
- Trilipix
- Trimel Pharmaceuticals
- Trimeris
- Triolex
- Tripos
- Tris Pharma
- Trisomy 21
- Trius Therapeutics
- Trizytek
- TroVax
- Troy Wilson
- TRU-015
- TRU-016
- Trubion Pharmaceuticals
- Tuberculosis
- tumors
- Tygacil
- Tykerb
- Type 1 Diabetes
- Type 2 Diabetes
- Tyrian Diagnostics
- Tysabri
- Tyvaso
- TZP-101
- U.S. Oncology
- U3
- UBC Group
- UCB
- UK
- Uloric
- undefined
- Unigene Laboratories
- unions
- Unit Dose Budesonide
- United Arab Emirates
- United Kingdom
- United Therapeutics
- Universal vaccine
- University College of London
- University deal
- University of Miami
- University of Michigan
- University of Virginia
- upfront payment
- Uplyso
- Upsher-Smith Laboratories
- Upstate Pharma
- Urocidin
- Ursodiol
- ustekinumab
- UTRF
- V-Clip Pharmaceuticals
- Vaccines
- Vaccines Technologies
- Valcyte
- Valeant Pharmaceuticals
- ValenTx
- Valeritas
- Valstar
- Valtropin
- Vancomycin
- Vanda Pharmaceuticals
- Vanderbilt
- vandetanib
- Vantia Therapeutics
- Varian
- Vasogen
- Vasovist
- Vaxart
- Vaxfectin
- Vaxgen
- VaxInnate
- VC / M&A
- Vectibix
- Vectura Group
- Vegf Trap
- velafermin
- velaglucerase alfa
- Velcade
- Velcura Therapeutics
- velneperit
- Velocigene technology
- VenBio
- Venrock Associates
- Ventana
- VentiRx
- Ventura County
- venture capital firm
- Venture Capital fund
- Venus Remedies
- Verdezyne
- Verispan
- vernakalant
- Vernalis
- VeroScience
- Versartis
- vertex
- Verus Pharmaceuticals
- VGX Pharmaceuticals
- VIA Pharmaceuticals
- VIA-2291
- Viagra
- VIAject
- Viamet Pharmaceuticals
- Vibativ
- Vical
- vicriviroc
- Victory Pharma
- Victoza
- Vicuron Pharmaceuticals
- Vidaza
- Video Games
- Viiv
- Vilazodone
- Vimpat
- Vion Pharmaceuticals
- VioQuest
- Vioxx
- viprinex
- Viraferon
- Viragen
- Viral Genetics
- Virdante Pharmaceuticals
- Viread
- Virginia Tech
- ViroChem
- Viromed
- Viropharma
- Virosome Biologicals
- virus
- Vitae Pharmaceuticals
- Vital Therapies
- Vitamin C
- Vivalis
- Vivus
- Vladimir Martin
- VLST
- voclosporin
- voluntary recall
- Voreloxin
- Votrient
- VPRIV
- VRX698
- VX-770
- Wake Forest University School Of Medicine
- Wal-Mart
- Walgreen's
- Wall Street
- Warburg Pincus
- Warfarin
- Warner Chilcott
- Warren Cooper
- Warren Levy
- Washington
- Water Street Healthcare Partners
- Watson Pharmaceuticals
- Wave Biotech
- web marketing
- Welcome Trust
- WellGen
- Wellstat Therapeutics
- West Pharmaceutical
- Wex Pharmaceuticals
- Wilex
- Wisconsin
- Wockhardt
- Wolters Kluwer Health
- workforce
- workforce expansion
- World Health Organization
- WorldCare Clinical
- WuXi
- Wyeth
- Xanodyne
- Xarelto
- Xcelience
- Xcellerex
- Xeloda
- Xenazine
- Xencor
- Xenome
- Xenon
- Xenoport
- Xiaflex
- Xience
- Xifaxan
- XL139
- XL147
- XL184
- XL228
- XL281
- XL413
- XL647
- XL765
- XL784
- XL880
- Xoma
- XOMA 052
- Xomaxon
- XORI
- Xphase Pharmaceuticals
- XTL Biopharmaceuticals
- Yasuchika Hasegawa
- YM Biosciences
- Yondelis
- York Pharma
- Yoshihiko Hatanaka
- young scientists
- ZabeCor
- Zactima
- ZafGen
- Zalbin
- Zambon
- Zavesca
- ZD4054
- Zealand Pharma
- Zebinix
- Zeldox
- Zelnorm
- Zelrix
- Zeltia
- Zentiva
- Zenvia
- Zenyaku Kogyo
- Zerenex
- Zevalin
- Zila
- Zingo
- Ziopharm Oncology
- Zocor
- Zogenix
- Zolpimist
- Zosano Pharma
- ZP1846
- Zuplenz
- Zydus Pharmaceuticals
- Zymafos
- ZymoGenetics
- Zyngenia
- Zyprexa
